Get the Stockscreener App
17.79
1.54%
0.27
Progyny Inc stock is traded at $17.79, with a volume of 2.37M.
It is up +1.54% in the last 24 hours and down -21.87% over the past month.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
See More
Previous Close:
$17.52
Open:
$17.54
24h Volume:
2.37M
Relative Volume:
1.61
Market Cap:
$1.53B
Revenue:
$1.13B
Net Income/Loss:
$62.75M
P/E Ratio:
28.24
EPS:
0.63
Net Cash Flow:
$170.92M
1W Performance:
-16.60%
1M Performance:
-21.87%
6M Performance:
-24.49%
1Y Performance:
-17.49%
1-Day Range:
$17.37
$18.07
1-Week Range:
$16.75
$22.33
52-Week Range:
$16.75
$28.75
Progyny Inc Stock (PGNY) Company Profile
Name
Progyny Inc
Sector
Industry
Phone
212-888-3124
Address
1359 BROADWAY, NEW YORK, NY
Compare PGNY vs UNH, CVS, CI, ELV, CNC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
17.79 | 1.51B | 1.13B | 62.75M | 170.92M | 0.63 |
|
UNH
Unitedhealth Group Inc
|
291.96 | 261.98B | 447.57B | 12.81B | 16.08B | 13.19 |
|
CVS
Cvs Health Corp
|
80.57 | 102.40B | 402.11B | 1.73B | 7.81B | 1.3835 |
|
CI
Cigna Group
|
284.74 | 74.81B | 274.88B | 6.29B | 8.39B | 22.19 |
|
ELV
Elevance Health Inc
|
291.45 | 62.69B | 199.13B | 5.66B | 3.17B | 25.11 |
|
CNC
Centene Corp
|
44.99 | 21.55B | 178.19B | 2.05B | 1.08B | 4.0447 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-20-26 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Jan-08-26 | Upgrade | Truist | Hold → Buy |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-12-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-08-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Dec-02-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-13-24 | Downgrade | Truist | Buy → Hold |
| Sep-19-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Aug-07-24 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Aug-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jul-16-24 | Initiated | JMP Securities | Mkt Outperform |
| May-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Sep-27-23 | Initiated | Canaccord Genuity | Buy |
| May-22-23 | Initiated | BTIG Research | Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-05-23 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-07-22 | Initiated | Truist | Buy |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-22-21 | Downgrade | Citigroup | Buy → Neutral |
| Sep-30-21 | Initiated | Berenberg | Buy |
| Aug-12-21 | Initiated | Barclays | Overweight |
| Jun-02-21 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Mar-10-21 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Jun-02-20 | Initiated | Guggenheim | Buy |
| Nov-19-19 | Initiated | Citigroup | Buy |
| Nov-19-19 | Initiated | Goldman | Buy |
| Nov-19-19 | Initiated | JP Morgan | Overweight |
| Nov-19-19 | Initiated | Piper Jaffray | Overweight |
| Nov-19-19 | Initiated | SVB Leerink | Outperform |
View All
Progyny Inc Stock (PGNY) Latest News
Progyny, Inc. (NASDAQ:PGNY) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Insider Selling: Progyny (NASDAQ:PGNY) EVP Sells 4,657 Shares of Stock - MarketBeat
Progyny (NASDAQ:PGNY) EVP Allison Swartz Sells 2,199 Shares - MarketBeat
[Form 4] Progyny, Inc. Insider Trading Activity - Stock Titan
Progyny (PGNY) EVP Allison Swartz receives equity grants and sells shares - Stock Titan
Progyny (NASDAQ: PGNY) CEO receives RSUs, options and withholds shares for taxes - Stock Titan
Allison C. Swartz sells shares; PGNY (NASDAQ: PGNY) Form 144 notice - Stock Titan
Progyny: Transitional Headwinds Hide An Undervalued Platform (NASDAQ:PGNY) - Seeking Alpha
Is Progyny (PGNY) Attractive After Recent Share Price Weakness And DCF Upside? - simplywall.st
Progyny, Inc. Hits Day Low of $16.75 Amid Price Pressure - Markets Mojo
Progyny's Valuation Upgrade Reflects Improved Financial Metrics Amid Market Dynamics - Markets Mojo
Progyny, Inc. Hits New 52-Week Low at $16.75 Amid Declining Performance - Markets Mojo
Allison Swartz to sell 4,657 PGNY shares (NASDAQ: PGNY) in vesting sale - Stock Titan
Progyny, Inc. (PGNY) Stock Analysis: Potential 68% Upside with Strong Buy Ratings in Healthcare Sector - DirectorsTalk Interviews
INVO Fertility's Wisconsin Clinic Joins Progyny Network - Bitget
INVO Fertility (IVF) Clinic Joins Progyny Network, Expanding Pat - GuruFocus
INVO Fertility’s Wisconsin Clinic Joins Progyny Network - marketscreener.com
Progyny deal brings INVO fertility care in-network in Wisconsin - Stock Titan
Progyny (PGNY): Truist Securities Lowers Price Target to $28 | P - GuruFocus
JPMorgan Chase & Co. Trims Position in Progyny, Inc. $PGNY - MarketBeat
Intech Investment Management Boosts Progyny Stake by 336% - National Today
Price-Driven Insight from (PGNY) for Rule-Based Strategy - Stock Traders Daily
PGNY (NASDAQ: PGNY) insider sale notice lists 2,199 common shares - Stock Titan
PGNY Sees Revised Price Target Despite Maintained Overweight Rat - GuruFocus
Progyny (NASDAQ:PGNY) Given New $28.00 Price Target at KeyCorp - MarketBeat
KeyBanc lowers Progyny stock price target on conservative estimates By Investing.com - Investing.com Canada
KeyBanc lowers Progyny stock price target on conservative estimates - Investing.com
Vanguard Group Inc. Has $217.48 Million Holdings in Progyny, Inc. $PGNY - MarketBeat
Truist Cuts Price Target on Progyny to $28 From $34, Keeps Buy Rating - marketscreener.com
Truist cuts Progyny stock price target on covered lives miss - Investing.com South Africa
Truist cuts Progyny stock price target on covered lives miss By Investing.com - Investing.com Nigeria
Intech Investment Management LLC Acquires 130,885 Shares of Progyny, Inc. $PGNY - MarketBeat
Short Interest in Progyny, Inc. (NASDAQ:PGNY) Increases By 41.0% - MarketBeat
Progyny (PGNY) Valuation In Focus After Recent Share Price Weakness - simplywall.st
Progyny, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Progyny (PGNY) Gets a Hold from Canaccord Genuity - The Globe and Mail
Why Progyny (PGNY) Shares Are Trading Lower Today - The Globe and Mail
Decoding Progyny Inc (PGNY): A Strategic SWOT Insight - GuruFocus
Progyny stock hits 52-week low at 17.95 USD By Investing.com - Investing.com Australia
Progyny (NASDAQ:PGNY) Releases Earnings Results, Beats Estimates By $0.10 EPS - MarketBeat
Progyny, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:PGNY) 2026-02-27 - Seeking Alpha
Tranche Update on Progyny, Inc.'s Equity Buyback Plan announced on November 6, 2025. - marketscreener.com
Progyny (NASDAQ:PGNY) Reaches New 1-Year LowTime to Sell? - MarketBeat
Progyny Q4 2025 Earnings: Revenue Beat, Cautious 2026 OutlookNews and Statistics - IndexBox
Progyny stock hits 52-week low at 17.95 USD - Investing.com South Africa
Progyny, Inc. SEC 10-K Report - TradingView
Sector Update: Health Care - marketscreener.com
Progyny (NASDAQ: PGNY) expands women’s health and fertility benefits platform - Stock Titan
Progyny Q4 2025 slides: margin expansion drives earnings beat By Investing.com - Investing.com India
Progyny Q4 Earnings Call Highlights - MarketBeat
Progyny Inc (PGNY) Q4 2025 Earnings Call Highlights: Record Reve - GuruFocus
Progyny Inc Stock (PGNY) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):